Intro

This chapter delves into the management of high-risk smoldering multiple myeloma utilizing daratumumab and discusses findings from a pivotal phase 3 trial that underscores the benefits of early intervention. It also explores BCG revaccination strategies for tuberculosis prevention and includes expert commentary on recent clinical insights.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app